Sutro Biopharma (STRO) EPS (Basic) (2017 - 2026)
Sutro Biopharma (STRO) posted EPS (Basic) of -$5.5 for Q4 2025, up 17.87% sequentially from -$6.7 in Q3 2025, and up 41.65% YoY from -$3.88 in Q4 2024.
Sutro Biopharma (STRO) EPS (Basic) (2017 - 2026) Analysis & Trends
Sutro Biopharma has reported EPS (Basic) for 9 years, with the latest figure at -$5.5 in Q4 2025.
- Quarterly EPS (Basic) rose 41.65% year-over-year to -$5.5 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$21.5 (up 27.37% YoY) and the FY2025 annual result came in at -$22.49, up 24.05% from the prior year.
- EPS (Basic) rose to -$5.5 in Q4 2025 per STRO's latest filing, from -$6.7 in the prior quarter.
- Over five years, EPS (Basic) peaked at $5.16 in Q4 2023 and troughed at -$9.47 in Q1 2024.
- A 5-year average of -$5.77 and a median of -$6.54 in 2023 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) slumped 315.25% in 2022, then surged 175.71% in 2023.
- Over 5 years, EPS (Basic) stood at -$8.27 in 2021, then advanced by 17.52% to -$6.82 in 2022, then soared by 175.71% to $5.16 in 2023, then tumbled by 282.66% to -$9.43 in 2024, then soared by 41.65% to -$5.5 in 2025.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$5.5, -$6.7, and -$1.36 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Sutro Biopharma | 339.58 Mn | 175.24 Mn | - | -2.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.53 |
| Dec 31, 2025 | -5.50 |
| Sep 30, 2025 | -6.70 |
| Jun 30, 2025 | -1.36 |
| Mar 31, 2025 | -8.14 |
| Dec 31, 2024 | -9.43 |
| Sep 30, 2024 | -5.95 |
| Jun 30, 2024 | -5.91 |
| Mar 31, 2024 | -9.47 |
| Dec 31, 2023 | 5.16 |
| Sep 30, 2023 | -8.13 |
| Jun 30, 2023 | -6.38 |
| Mar 31, 2023 | -8.52 |
| Dec 31, 2022 | -6.82 |
| Sep 30, 2022 | -3.72 |
| Jun 30, 2022 | -5.54 |
| Mar 31, 2022 | -8.41 |
| Dec 31, 2021 | -8.27 |
| Sep 30, 2021 | -6.69 |
| Jun 30, 2021 | -1.33 |